Fossella FV - Search Results

1

Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: a review of two phase III trials.

Shepherd FA, Fossella FV, Lynch T, Armand JP, Rigas JR, Kris MG. Shepherd FA, et al. Among authors: fossella fv. Semin Oncol. 2001 Feb;28(1 Suppl 2):4-9. doi: 10.1016/s0093-7754(01)90297-0. Semin Oncol. 2001. PMID: 11284623 Review.

2

Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial.

Liu Y, Yao L, Kalhor N, Carter BW, Altan M, Blumenschein G, Byers LA, Fossella F, Gibbons DL, Kurie JM, Lu C, Skoulidis F, Chang JY, Liao Z, Gomez DR, O'Reilly M, Heymach JV, Tsao AS, Lin SH. Liu Y, et al. Lung Cancer. 2022 Dec;174:112-117. doi: 10.1016/j.lungcan.2022.10.006. Epub 2022 Oct 29. Lung Cancer. 2022. PMID: 36371941 Clinical Trial.

3

Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.

Fossella FV, Lee JS, Berille J, Hong WK. Fossella FV, et al. Semin Oncol. 1995 Apr;22(2 Suppl 4):22-9. Semin Oncol. 1995. PMID: 7740327 Review.

4

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.

Fossella FV, Lee JS, Shin DM, Calayag M, Huber M, Perez-Soler R, Murphy WK, Lippman S, Benner S, Glisson B, et al. Fossella FV, et al. J Clin Oncol. 1995 Mar;13(3):645-51. doi: 10.1200/JCO.1995.13.3.645. J Clin Oncol. 1995. PMID: 7884425 Clinical Trial.

5

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.

Fossella FV, Lee JS, Murphy WK, Lippman SM, Calayag M, Pang A, Chasen M, Shin DM, Glisson B, Benner S, et al. Fossella FV, et al. J Clin Oncol. 1994 Jun;12(6):1238-44. doi: 10.1200/JCO.1994.12.6.1238. J Clin Oncol. 1994. PMID: 7911160 Clinical Trial.

6

Management strategies for recurrent non-small cell lung cancer.

Fossella FV, Lee JS, Hong WK. Fossella FV, et al. Semin Oncol. 1997 Aug;24(4):455-62. Semin Oncol. 1997. PMID: 9280225 Review.

7

Paclitaxel/carboplatin chemotherapy as primary treatment of brain metastases in non-small cell lung cancer: a preliminary report.

Lee JS, Pisters KM, Komaki R, Glisson BS, Khuri FR, Schea R, Fossella FV. Lee JS, et al. Among authors: fossella fv. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-52-S12-55. Semin Oncol. 1997. PMID: 9331122 Clinical Trial.

8

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

Bruno R, Hille D, Riva A, Vivier N, ten Bokkel Huinnink WW, van Oosterom AT, Kaye SB, Verweij J, Fossella FV, Valero V, Rigas JR, Seidman AD, Chevallier B, Fumoleau P, Burris HA, Ravdin PM, Sheiner LB. Bruno R, et al. Among authors: fossella fv. J Clin Oncol. 1998 Jan;16(1):187-96. doi: 10.1200/JCO.1998.16.1.187. J Clin Oncol. 1998. PMID: 9440742 Clinical Trial.

9

Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement.

Roth JA, Swisher SG, Merritt JA, Lawrence DD, Kemp BL, Carrasco CH, El-Naggar AK, Fossella FV, Glisson BS, Hong WK, Khurl FR, Kurie JM, Nesbitt JC, Pisters K, Putnam JB, Schrump DS, Shin DM, Walsh GL. Roth JA, et al. Among authors: fossella fv. Semin Oncol. 1998 Jun;25(3 Suppl 8):33-7. Semin Oncol. 1998. PMID: 9704675 Clinical Trial.

10

Overview of docetaxel (Taxotere) in the treatment of non-small cell lung cancer.

Fossella FV. Fossella FV. Semin Oncol. 1999 Jun;26(3 Suppl 11):4-8. Semin Oncol. 1999. PMID: 10458203 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page